Akebia Therapeutics, Inc. (AKBA)

Akebia Therapeutics Revenue

Akebia Therapeutics had revenue of $37.43M in the quarter ending September 30, 2024, a decrease of -10.98%. This brings the company's revenue in the last twelve months to $169.88M, down -12.53% year-over-year. In the year 2023, Akebia Therapeutics had annual revenue of $194.62M, down -33.46%.

• Revenue (ttm): $169.88M
• Revenue Growth: -12.53%
• P/S Ratio: 2.15
• Revenue / Employee: $1,017,240
• Employees: 167
• Market Cap: 390.54M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	194.62M	-97.86M	-33.46%
Dec 31, 2022	292.48M	80.83M	38.19%
Dec 31, 2021	211.65M	-82.99M	-28.17%
Dec 31, 2020	294.64M	-40.36M	-12.05%
Dec 31, 2019	335.00M	127.26M	61.26%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.